Hype
Trump Administration Health Officials Explore Antidepressant Ban
2026-05-10 · 1 sources · 80% confidence
Hype
59.0
Media Hype
Significant
+35 HYPE
IF YOU ONLY DO ONE THING
Monitor whether this 'exploration' translates into actual FDA rulemaking or agency directives; demand transparency on which officials proposed this and what scientific evidence they cited.
Why This Score
This scores high on distraction (B=71) due to extreme outrage potential and media-friendliness around banning widely-used medications, yet remains exploratory with no actual policy implementation. Constitutional harm is moderate (A=30) primarily from institutional capture concerns—health officials exploring medically dubious bans suggests ideological override of scientific expertise—but lacks concrete action or irreversible damage. The 'explored' framing maximizes headlines while minimizing accountability.
Damage Score Drivers
Election Integrity & Transfer of Power×0.22
0.0/5
Rule of Law / Due Process×0.18
1.0/5
Separation of Powers×0.16
2.0/5
Civil Rights / Equal Protection×0.14
2.0/5
Institutional Capture×0.14
3.0/5
Corruption / Self-Dealing×0.1
0.0/5
Violence / Intimidation Enabling×0.06
0.0/5
Sev: durability=0.8 · reversibility=0.8 · precedent=1 · mech=1.05× scope=1.1×
Hype Score: Layer 1 — Hype (55%)
Outrage-bait
4.0/5
Meme-ability
3.0/5
Novelty Spike
4.0/5
Media Friendliness
5.0/5
Layer 2 — Strategic (45%)
Media-Volume Mismatch
4.0/5
Timing Overlap
3.0/5
Narrative Pivot
3.0/5
Repeat Pattern Match
2.0/5
Intentionality: 7/15 → Reduced (0.25)
Covering For
DOJ Denaturalization and Citizenship Revocation Campaign
SI: 29.4 🟡 · Displacement: MED
DOJ Denaturalization Push Against 12 People
SI: 26.7 🟡 · Displacement: MED
Trump State-by-State Election Control Plan
SI: 50.2 🔴 · Displacement: MED